eClinical Solutions Market Analysis To Reach $12.8 Billion By 2024
eClinical solutions market is expected to reach USD 12.8 billion by 2024, according to a new report published by Grand View Research Inc. The eClinical solutions market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors attributing towards the growth of the market are increase in the research and development activities by numerous biopharma and pharma companies, increasing application of software solutions in clinical trials, upsurge in the government funding to promote clinical research programs, rise in the number of Contract Research Organizations (CROs) and life sciences organizations, and increasing customer base.
Additionally, factors such as increasing outsourcing of clinical trials to CROs, escalating clinical research programs in Asian countries, as well as, the development of cost-effective modules are expected to be opportunistic for the industry growth. However, the shortage of skilled labor force, high implementation costs of the eClinical solutions and the lack of awareness of clinical data sciences software in the research community are likely to hinder the growth of the market in the near future.
The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, end-user, and region. Based on the product, the industry is categorized into clinical analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF).
The other segments of the market include delivery mode (web-hosted, licensed enterprise, and cloud-based), clinical trial phases (phase I, phase II, phase III, and phase IV), and end-user application (consulting service companies, medical device manufacturers, hospitals, contract research organizations, pharmaceutical, and biopharmaceutical companies). On the basis of regions, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa).
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market
Additionally, factors such as increasing outsourcing of clinical trials to CROs, escalating clinical research programs in Asian countries, as well as, the development of cost-effective modules are expected to be opportunistic for the industry growth. However, the shortage of skilled labor force, high implementation costs of the eClinical solutions and the lack of awareness of clinical data sciences software in the research community are likely to hinder the growth of the market in the near future.
The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, end-user, and region. Based on the product, the industry is categorized into clinical analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF).
The other segments of the market include delivery mode (web-hosted, licensed enterprise, and cloud-based), clinical trial phases (phase I, phase II, phase III, and phase IV), and end-user application (consulting service companies, medical device manufacturers, hospitals, contract research organizations, pharmaceutical, and biopharmaceutical companies). On the basis of regions, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa).
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market